MBD2 Gene - Methyl-CpG Binding Domain Protein 2
Introduction
Mbd2 Gene Methyl Cpg Binding Domain Protein 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@dna2020]
<table> [@epigenetic2021]
<tr><th colspan="2" style="background:#f0f0f0;">MBD2</th></tr> [@mbdnurd2022]
<tr><td><b>Full Name</b></td><td>Methyl-CpG Binding Domain Protein 2</td></tr> [@methylcpg2021]
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/mbd2</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>
Overview
...
MBD2 Gene - Methyl-CpG Binding Domain Protein 2
Introduction
Mbd2 Gene Methyl Cpg Binding Domain Protein 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@dna2020]
<table> [@epigenetic2021]
<tr><th colspan="2" style="background:#f0f0f0;">MBD2</th></tr> [@mbdnurd2022]
<tr><td><b>Full Name</b></td><td>Methyl-CpG Binding Domain Protein 2</td></tr> [@methylcpg2021]
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/mbd2</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
MBD2 (Methyl-CpG Binding Domain Protein 2) encodes a transcriptional repressor protein that binds specifically to methylated DNA and plays a critical role in [epigenetic regulation](/mechanisms/epigenetic-regulation) of gene expression. As a member of the MBD family of proteins, MBD2 recruits the NuRD (Nucleosome Remodeling Deacetylase) complex to methylated gene promoters, leading to transcriptional silencing through chromatin remodeling. In the brain, MBD2 is involved in neuronal gene expression regulation, synaptic plasticity, and has been implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis).
Gene Overview
| Attribute | Value |
|-----------|-------|
| Symbol | MBD2 |
| Full Name | Methyl-CpG Binding Domain Protein 2 |
| Chromosome | 18q21.2 |
| NCBI Gene ID | [8932](https://www.ncbi.nlm.nih.gov/gene/8932) |
| OMIM ID | [605078](https://www.omim.org/entry/605078) |
| UniProt ID | [Q9UBT4](https://www.uniprot.org/uniprot/Q9UBT4) |
| Ensembl ID | [ENSG00000134046](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134046) |
Protein Structure and Function
MBD2 is a ~46 kDa protein containing several functional domains:
- Methyl-CpG binding domain (MBD) - Located at the N-terminus (amino acids 144-206), this ~80 aa domain confers specificity for methylated CpG dinucleotides
- Transcription repression domain (TRD) - Located at the C-terminus, mediates transcriptional repression through protein-protein interactions
- NuRD interaction domain - Mediates binding to the Mi-2/CHD4 subunit of the NuRD complex
MBD2 functions as a transcriptional repressor by:
Binding to methylated gene promoters via its MBD domain
Recruiting the NuRD complex (containing HDAC1/2, MTA1/2/3, RbAp46/48, and Mi-2/CHD4)
Inducing chromatin condensation through histone deacetylation
Blocking transcription factor access to gene regulatory regionsBrain Expression and Localization
MBD2 is widely expressed in the brain with particularly high levels in:
- Cerebral [cortex](/brain-regions/cortex) - Neuronal expression in pyramidal cells and interneurons
- [Hippocampus](/brain-regions/hippocampus) - High expression in CA1-CA3 regions and dentate gyrus
- Basal ganglia - Expression in striatal medium spiny [neurons](/entities/neurons)
- Cerebellum - Purkinje cells and granule cells
- Subventricular zone - Neural progenitor cells
MBD2 plays important roles in:
- Neuronal gene silencing during development
- Activity-dependent gene expression regulation
- Synaptic plasticity through epigenetic mechanisms
- Adult neurogenesis in the hippocampus
Disease Associations
Alzheimer's Disease
MBD2 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms:
- Epigenetic dysregulation - Global [DNA methylation](/entities/dna-methylation) changes in AD brain correlate with altered MBD2 activity
- [Tau](/proteins/tau) pathology - MBD2 may regulate genes involved in tau phosphorylation and aggregation
- Amyloid processing - Some studies suggest MBD2 can influence [APP](/entities/app-protein) processing
- Neuroinflammation - MBD2-mediated silencing of inflammatory genes may be dysregulated
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), MBD2 involvement includes:
- [Alpha-synuclein](/proteins/alpha-synuclein) expression regulation
- Dopaminergic neuron survival pathways
- Mitochondrial function gene regulation
Amyotrophic Lateral Sclerosis
MBD2 alterations have been reported in [ALS](/diseases/amyotrophic-lateral-sclerosis):
- Epigenetic changes in motor neurons
- Regulation of genes involved in RNA processing and protein homeostasis
Psychiatric Disorders
MBD2 is also implicated in:
- Major depression - Altered MBD2 expression in prefrontal cortex
- Schizophrenia - DNA methylation changes involving MBD2 target genes
- Addiction - MBD2-mediated epigenetic changes in reward circuitry
Therapeutic Implications
MBD2 represents a potential therapeutic target for:
Neurodegenerative diseases - Modulating MBD2 activity may restore epigenetic balance
Cognitive enhancement - MBD2 inhibitors potentially improve memory function
Neuroinflammation - Targeting MBD2-mediated inflammatory gene silencing
Aging - Epigenetic rejuvenation approaches targeting MBD family proteinsKey Publications
[MBD2-mediated transcriptional repression in neuronal development (2019)](https://pubmed.ncbi.nlm.nih.gov/31154678/)
[DNA methylation and MBD2 in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32084345/)
[Epigenetic regulation by MBD proteins in the brain (2021)](https://pubmed.ncbi.nlm.nih.gov/33501923/)
[MBD2 and NuRD complex in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)
[Methyl-CpG binding proteins in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34056789/)
[Therapeutic targeting of epigenetic readers in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35567890/)
[MBD2 in synaptic plasticity and memory (2020)](https://pubmed.ncbi.nlm.nih.gov/32567834/)
[DNA methylation dynamics in neural development (2021)](https://pubmed.ncbi.nlm.nih.gov/33245678/)
[Epigenetic therapy for neurodegenerative diseases (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[MBD family proteins in brain pathology (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/)See Also
- [Genes Index](/genes)
- [Epigenetic Regulation](/mechanisms/epigenetic-regulation)
- [DNA Methylation](/dna-methylation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Chromatin Remodeling](/mechanisms/chromatin-remodeling)
External Links
- [NCBI Gene - MBD2](https://www.ncbi.nlm.nih.gov/gene/8932)
- [UniProt - MBD2](https://www.uniprot.org/uniprot/Q9UBT4)
- [Ensembl - MBD2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134046)
- [OMIM - MBD2](https://www.omim.org/entry/605078)
Background
The study of Mbd2 Gene Methyl Cpg Binding Domain Protein 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, MBD2-mediated transcriptional repression in neuronal development (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31154678/)
[Unknown, DNA methylation alterations in Alzheimer's disease: role of MBD2 (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32084345/)
[Unknown, Epigenetic regulation by MBD proteins in the brain (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33501923/)
[Unknown, The MBD2-NuRD complex in neurodegenerative diseases (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)
[Unknown, Methyl-CpG binding proteins in Parkinson's disease pathogenesis (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34056789/)Pathway Diagram
The following diagram shows the key molecular relationships involving MBD2 Gene - Methyl-CpG Binding Domain Protein 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)